Targeting cyclin-dependent kinases: From pocket specificity to drug selectivity

Area of Science:

• Medicinal Chemistry
• Structural Biology
• Pharmacology

Background:

• Cyclin-dependent kinases (CDKs) are crucial regulators of the cell cycle, making them important drug targets.
• Developing selective CDK inhibitors is challenging due to the high conservation of kinase pockets across the CDK family.
• Subtle structural differences in CDK pockets offer opportunities for achieving drug selectivity.

Purpose of the Study:

• To review structure-activity relationships (SARs) influencing selectivity in CDK drug development.
• To analyze pocket features enabling selectivity using molecular-protein binding models.
• To highlight novel CDK modulators that offer new strategies for achieving selectivity.

Main Methods:

• Analysis of existing literature on CDK inhibitors and their selectivity profiles.
• Examination of crystallographic data to identify structural differences in CDK pockets.
• Application of molecular-protein binding models to understand drug-target interactions.
• Inclusion of recent case studies on novel CDK modulator development.

Main Results:

• Exploiting subtle differences in CDK pockets is an effective strategy for achieving high drug selectivity.
• Understanding both target and off-target CDK structures is critical for selective inhibitor design.
• Novel CDK modulators demonstrate diverse approaches to achieving selectivity.
• SARs provide a framework for rational drug design targeting specific CDKs.

Conclusions:

• Detailed analysis of SARs and pocket features is essential for developing selective CDK inhibitors.
• Molecular modeling aids in predicting and optimizing selectivity based on structural insights.
• Emerging CDK modulators expand the therapeutic potential for targeting CDK-related diseases.
• This review provides a foundation for future development of targeted CDK-based therapies.